A new method for simultaneous multi-gene mutation screening in 355 patients with nonsyndromic hearing loss of Inner Mongolia Autonomous region
-
摘要: 目的: 利用新型快速多基因检测技术对内蒙古自治区355例非综合征性聋患者进行分子病因筛查,了解这些非综合征性聋患者的分子病因,对新型多基因检测技术进行验证。方法: 受检人群来自内蒙古自治区多地的特殊教育学校和聋儿康复中心的重度非综合征性聋患者,共355例。利用SNPscan技术对GJB2、SLC26A4、MT-12S rRNA这3个基因的115个位点进行检测。结果: 在355例非综合征性聋患者中共找到明确基因致聋的患者89例(25.07%)。其中明确GJB2基因突变致病的患者人数为53例(14.93%),纯合突变24例(6.76%),复合杂合突变29例(8.17%)。除此之外,还发现携带GJB2基因的单杂合突变者3例(0.85%)。明确SLC26A4突变致病的患者33例(9.30%),其中纯合突变15例(4.23%),复合杂合突变18例(5.07%)。除此之外,还发现SLC26A4基因的单杂合突变携带者5例(1.41%)。线粒体DNA12SrRNA A1555G 突变6例(1.69%),未发现mtDNA12S rRNA 1494C>T突变。结论: 应用SNPscan聋基因诊断技术可以在聋患者病因调查中进行准确、快速和经济有效的诊断筛查。SNPscan检测技术为大规模遗传性聋基因检测的开展提供了很好的诊断工具,值得广泛推广应用。Abstract: Objective: Using simultaneous multi-gene mutation screening to survey the molecular epidemiological basis of 355 patients with nonsyndromic hearing loss of Inner Mongolia Autonomous region, we can identify the causes of their deafness,and verify the new method for simultaneous multi-gene mutation screening.Method: Three hundred and fifty-five patients with severe non-syndromic deafness from Inner Mongolia Autonomous region were included in the study. The SNPscan technology was used for screening the 115 spots mutations in three common deafness-related genes(GJB2, SLC26A4,MT-12S rRNA) of patients with nonsyndromic hearing loss of Inner Mongolia Autonomous region.Result: In 355 patients,there were 89 cases of deafness caused by mutation (25.07%). 53 patients with the GJB2 mutations were found(14.93%),including 24 cases of homozygous mutations (6.76%),29 patients (8.17%) of compound heterozygous mutations,and 3 cases (0.85%) of single heterozygous mutations. 33 patients with the SLC26A4 mutations were found(9.30%),including 15 cases of homozygous mutations(4.23%),18 patients (5.07%) of compound heterozygous mutations,and 5 cases (1.41%) of single heterozygous mutations.mtDNA12S rRNA A1555G mutation was found in 6 patients (1.69%). mtDNA12S rRNA 1494C>T mutation was not found.Conclusion: SNPscan technology allows accurate, rapid and cost-effective diagnostic screening in patients with hearing loss for etiology investigation. The SNPscan technology can serve as a good diagnostic tool for large-scale genetic testing for hereditary deafness and should be widely applied.
-
Key words:
- SNPscan /
- GJB2 /
- SLC26A4 /
- mitochondrial mutations /
- non-syndromic deafness
-
[1] COLLINS F S, GELEHRTER T D.医学遗传学原理[M].孙开来,赵彦艳,熊第志,译.北京:科学出版社, 2001:190-197.
[2] DE LA LUZ ARENAS-SORDO M, MENENDEZ I,HERNANDEZ-ZAMORA E, et al.Uniquespectrumof GJB2 mutations in Mexico[J]. Int J Pediatr. Otorhinolaryngol,2012,76:1678-1680.
[3] MATOS T D,SIMOES-TEIXEIRA H,CARIA H,et al.Spectrum and frequency of GJB2 mutationsin a cohort of 264 Portuguese nonsyndromic sensorineural hearing losspatients[J]. Int J Audiol,2013,52:466-471.
[4] DAI P,YU F,HAN B, et al.GJB2 mutation spectrum in 2,063 Chinese patients withnonsyndromic hearing impairment[J].J Transl Med,2009,7:26-26.
[5] OHTSUKA A, I YUGE,KIMURA S, et al.GJB2 deafness gene shows a specific spectrumofmutations in Japan, including a frequent foundermutation[J]. Hum Genet,2003,112:329-333.
[6] SNOECKX R L, HUYGEN P L,FELDMANN D, et al.GJB2 mutations and degree of hearingloss:a multicenter study[J]. Am J Hum. Genet,2005,77:945-957.
[7] CHEN Y,M TUDI,SUN J, et al.Geneticmutations in non-syndromic deafness patientsof Uyghur and Han Chinese ethnicities in Xinjiang, China:a comparative study[J]. J Transl Med,2011,9:154-154.
[8] LU J,LI Z, ZHU Y, et al.Mitochondrial 12S rRNA variants in 1642 Han Chinese pediatricsubjects with aminoglycoside-induced and nonsyndromic hearing loss[J].Mitochondrion,2010,10:380-390.
[9] LIU X, DAI P, HUANG D L, et al.Large-scale screening of mtDNAA1555Gmutation in China and its significance in prevention of aminoglycoside antibiotic induced deafness[J]. Zhong Hua Yi Xue Za Zhi,2006,86:1318-1322.
[10] SHEN Z,ZHENG J, B CHEN, et al. Frequency and spectrum ofmitochondrial 12S rRNAvariants in 440 Han Chinese hearing impaired pediatric subjects from two otologyclinics[J]. J Transl Med,2011,9:4.
[11] GUTIERREZ CORTES N,PERTUISET C,DUMON E, et al.Novel mitochondrial DNA mutationsresponsible for maternally inherited nonsyndromic hearing loss[J]. Hum Mutat,2012,33:681-689.
[12] CHAI Y, HUANG Z, TAO Z, et al.Molecular etiology of hearing impairmentassociatedwith nonsyndromic enlarged vestibular aqueduct in East China[J]. Am J Med Genet A,2013,161:2226-2233.
[13] ANWAR S,RIAZUDDIN S, AHMED Z M, et al.SLC26A4 mutation spectrumassociatedwith DFNB4 deafness and Pendred's syndrome in Pakistanis[J]. J Hum Genet,2009,54:266-270.
[14] PARK H J, LEE S J, JIN H S, et al.Genetic basis of hearing loss associatedwith enlargedvestibular aqueducts in Koreans[J]. Clin Genet,2005,67:160-165.
[15] WANG Q J, ZHAO Y L,RAO S Q, et al.A distinct spectrumof SLC26A4mutations in patientswith enlarged vestibular aqueduct in China[J]. Clin Genet,2007,27:245-254.
[16] DAI P, LI Q, HUANG D, et al.SLC26A4 c.919-2ANG varies among Chineseethnicgroups as a cause of hearing loss[J]. Genet Med,2008,10:586-592.
[17] YUAN Y, YOU Y, HUANG D, et al.Comprehensive molecular etiology analysis of nonsyndromichearing impairment from typical areas in China[J]. J Transl Med,2009,7:79-79.
[18] POUROVA R,JANOUSEK P, JUROVCIK M, et al.Spectrum and frequency of SLC26A4 mutationsamong Czech patients with early hearing loss with and without Enlarged Vestibular Aqueduct[J]. Ann Hum Genet,2010,74:299-307.
[19] ALBERT S, BLONS H, JONARD L, et al.SLC26A4 gene is frequently involved in nonsyndromichearing impairment with enlarged vestibular aqueduct in Caucasian populations[J]. Eur J Hum Genet,2006,14:773-779.
[20] YUANY, ZHANG X, HUANG S, et al.Common molecular etiologies are rare in nonsyndromicTibetan Chinese patients with hearing impairment[J]. PLoS One,2012,7:e30720-e30720.
[21] CHOI Y H,MILLER J M,TUCKER K L, et al. Antioxidant vitamins and magnesium and the risk of hearing loss in the US general population[J]. Am J Clin Nutr,2014,99:148-155.
计量
- 文章访问数: 74
- PDF下载数: 63
- 施引文献: 0